The World Health Organization (WHO) has announced the upcoming Sixtieth meeting of the Expert Committee on Specifications for Pharmaceutical Preparations, to be held from October 12-16, 2026, at WHO headquarters in Geneva. This committee plays a crucial role in advising the Director-General on the quality assurance of medicines, overseeing The International Pharmacopoeia, and providing guidance to regulatory authorities in Member States to ensure medicines meet unified standards of quality, safety, and efficacy. The committee also recommends regulatory guidelines for multisource medicines intended for global use.

This meeting is primarily informational, serving as a platform for discussion and recommendation regarding pharmaceutical quality standards. While it does not impose immediate compliance obligations or deadlines on regulated entities, it informs the development of future guidelines and standards that pharmaceutical manufacturers and regulatory authorities worldwide will need to adhere to. Compliance officers should note the committee's role in shaping international pharmacopoeial standards and regulatory guidelines.